老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Inhibrx Biosciences

12.32
-0.0100-0.08%
盤後：12.320.00000.00%16:20 EDT
成交量：8.63萬
成交額：107.18萬
市值：1.78億
市盈率：0.11
高：12.82
開：12.33
低：12.09
收：12.33
資料載入中...
總覽公司新聞公告
2020/11/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/13

重要事件披露

8-K - Current report
2020/11/12

重要事件披露

8-K - Current report
2020/09/11

重要事件披露

8-K - Current report
2020/08/31

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/08/21

重要事件披露

8-K - Current report
2020/08/19

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/08/14

SEC問詢函

CORRESP [Cover] - Correspondence
2020/08/14

SEC問詢函

CORRESP [Cover] - Correspondence
2020/08/12

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/08/05

SEC問詢函

CORRESP [Cover] - Correspondence
2020/08/03

SEC問詢函

CORRESP [Cover] - Correspondence
2020/07/28

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/07/27

SEC問詢函

CORRESP [Cover] - Correspondence
2019/08/20

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2019/06/03

SEC問詢函

CORRESP [Cover] - Correspondence
2019/06/03

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933